Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: An interim report

British Journal of Cancer

Volumn 73, Issue 12, 1996, Pages 1455-1462

  Saunders, M I ^a   Dische, S ^a   Barrett, A ^b   Parmar, M K B ^c   Harvey, A ^c   Gibson, D ^c  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Continuous hyperfractionated accelerated radiation therapy; Head and neck cancer; Non small cell lung cancer; Randomised trials

Indexed keywords

ADULT; AGED; ANALYSIS; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030037679     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.276     Document Type: Article

References (19)

1. BEGG AC, MCNALLY NJ, SHRIEVE DC AND KARCHER HA. (1985). A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry, 6, 620-626.
2. BENNETT MH, WILSON GD, DISCHE S, SAUNDERS MI, MARTINDALE CA AND O'HALLORAN A. (1992). Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer, 65, 870-878.
3. CHARBIT A, MALAISE EP AND TUBIANA M. (1971). Relation between the pathological nature and the growth rate of human tumors. Eur. J. Cancer, 7, 307-315.
4. DENEKAMP J. (1982). Cell Kinetics and Cancer Therapy. Thomas: Springfield, IL.
5. DISCHE S. (1992). The clinical science of radiation oncology. Radiother. Oncol., 28, 93-107.
6. DISCHE S AND SAUNDERS MI. (1995). Clinical fractionation studies. In Oxford Textbook of Oncology, Peckham M, Pinedo HM and Veronesi U. (eds), pp 796-810. Oxford Medical Publications: Oxford.
7. FOWLER JF. (1989). The linear quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol., 62, 679-694.
8. HOPEWELL JW AND VAN DEN AARDWEG GJMJ. (1991). Studies of dose-fractionation on early and late responses in pig skin: a reappraisal of the importance of the overall treatment time and its effects on radiosensitization and incomplete repair. Int. J. Radial. Oncol. Biol. Phys., 21, 1441-1450.
9. HORIOT JC, LE FUR R, N'GUYEN T, CHENAL C, SCHRAUB S, ALFONSI S, GARDANI G, VAN DEN BOGAERT W, DANCZAK S, BOLLA M, VAN GLABBEKE M AND DE PAUW M. (1992). Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother. Oncol., 25, 231-241.
10. INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS. (1978). Dose specification of reporting external beam therapy with photons and electrons. ICRU Report No. 29. ICRU: Washington, DC.
11. JONES A. (1964). Transient radiation myelopathy. Br. J. Radiol., 37, 727-744.
12. OLMI P, CEKKAU E, CHIAVACCI A AND FALLAI C. (1990). Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae. Radiother. Oncol., 17, 199-207.
13. PARMAR MKB AND MACHIN D. (1995). Survival Analysis: A Practical Approach. John Wiley: Chichester.
14. PERACCHIA G AND SALTI C. (1981). Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences. Int. J. Radiat. Oncol. Biol. Phys., 7, 99-104.
15. SAUNDERS MI. (1991). Is the control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus? Clin. Oncol., 3, 185-188.
16. SAUNDERS MI, DISCHE S, GROSCH E, FERMONT DC, ASHFORD RFU, MAHER EJ AND MAKEPEACE A. (1991). Experience with CHART. Int. J. Radial. Oncol. Biol. Phys., 21, 871-878.
17. TUBIANA M. (1988). Repopulation in human tumours a biological background for fractionation in radiotherapy. Acta. Oncol., 27, 83-88.
18. VAN DEN KOGEL AJ. (1989). Editorial. Continuous, hyperfractionated, accelerated radiotherapy (CHART). Radiother. Oncol., 16, 75-77.
19. WITHERS HR. (1992). Biological basis of radiation therapy for cancer. Lancet, 339, 156-159.